340 related articles for article (PubMed ID: 23867502)
1. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.
Gee HY; Saisawat P; Ashraf S; Hurd TW; Vega-Warner V; Fang H; Beck BB; Gribouval O; Zhou W; Diaz KA; Natarajan S; Wiggins RC; Lovric S; Chernin G; Schoeb DS; Ovunc B; Frishberg Y; Soliman NA; Fathy HM; Goebel H; Hoefele J; Weber LT; Innis JW; Faul C; Han Z; Washburn J; Antignac C; Levy S; Otto EA; Hildebrandt F
J Clin Invest; 2013 Aug; 123(8):3243-53. PubMed ID: 23867502
[TBL] [Abstract][Full Text] [Related]
2. Disease-causing mutations of RhoGDIα induce Rac1 hyperactivation in podocytes.
Auguste D; Maier M; Baldwin C; Aoudjit L; Robins R; Gupta IR; Takano T
Small GTPases; 2016 Apr; 7(2):107-21. PubMed ID: 26726844
[TBL] [Abstract][Full Text] [Related]
3. ARHGDIA: a novel gene implicated in nephrotic syndrome.
Gupta IR; Baldwin C; Auguste D; Ha KC; El Andalousi J; Fahiminiya S; Bitzan M; Bernard C; Akbari MR; Narod SA; Rosenblatt DS; Majewski J; Takano T
J Med Genet; 2013 May; 50(5):330-8. PubMed ID: 23434736
[TBL] [Abstract][Full Text] [Related]
4. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
5. FAT1 mutations cause a glomerulotubular nephropathy.
Gee HY; Sadowski CE; Aggarwal PK; Porath JD; Yakulov TA; Schueler M; Lovric S; Ashraf S; Braun DA; Halbritter J; Fang H; Airik R; Vega-Warner V; Cho KJ; Chan TA; Morris LG; ffrench-Constant C; Allen N; McNeill H; Büscher R; Kyrieleis H; Wallot M; Gaspert A; Kistler T; Milford DV; Saleem MA; Keng WT; Alexander SI; Valentini RP; Licht C; Teh JC; Bogdanovic R; Koziell A; Bierzynska A; Soliman NA; Otto EA; Lifton RP; Holzman LB; Sibinga NE; Walz G; Tufro A; Hildebrandt F
Nat Commun; 2016 Feb; 7():10822. PubMed ID: 26905694
[TBL] [Abstract][Full Text] [Related]
6. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
Ashraf S; Gee HY; Woerner S; Xie LX; Vega-Warner V; Lovric S; Fang H; Song X; Cattran DC; Avila-Casado C; Paterson AD; Nitschké P; Bole-Feysot C; Cochat P; Esteve-Rudd J; Haberberger B; Allen SJ; Zhou W; Airik R; Otto EA; Barua M; Al-Hamed MH; Kari JA; Evans J; Bierzynska A; Saleem MA; Böckenhauer D; Kleta R; El Desoky S; Hacihamdioglu DO; Gok F; Washburn J; Wiggins RC; Choi M; Lifton RP; Levy S; Han Z; Salviati L; Prokisch H; Williams DS; Pollak M; Clarke CF; Pei Y; Antignac C; Hildebrandt F
J Clin Invest; 2013 Dec; 123(12):5179-89. PubMed ID: 24270420
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
Zhu Y; Casey PJ; Kumar AP; Pervaiz S
Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
[TBL] [Abstract][Full Text] [Related]
8. MLL regulates the actin cytoskeleton and cell migration by stabilising Rho GTPases via the expression of RhoGDI1.
Chinchole A; Lone KA; Tyagi S
J Cell Sci; 2022 Oct; 135(20):. PubMed ID: 36111497
[TBL] [Abstract][Full Text] [Related]
9. Loss of Rho-GDIα sensitizes podocytes to lipopolysaccharide-mediated injury.
Robins R; Baldwin C; Aoudjit L; Gupta IR; Takano T
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1207-16. PubMed ID: 25503727
[TBL] [Abstract][Full Text] [Related]
10. PLCE1 regulates the migration, proliferation, and differentiation of podocytes.
Yu S; Choi WI; Choi YJ; Kim HY; Hildebrandt F; Gee HY
Exp Mol Med; 2020 Apr; 52(4):594-603. PubMed ID: 32238860
[TBL] [Abstract][Full Text] [Related]
11.
Hermle T; Schneider R; Schapiro D; Braun DA; van der Ven AT; Warejko JK; Daga A; Widmeier E; Nakayama M; Jobst-Schwan T; Majmundar AJ; Ashraf S; Rao J; Finn LS; Tasic V; Hernandez JD; Bagga A; Jalalah SM; El Desoky S; Kari JA; Laricchia KM; Lek M; Rehm HL; MacArthur DG; Mane S; Lifton RP; Shril S; Hildebrandt F
J Am Soc Nephrol; 2018 Aug; 29(8):2123-2138. PubMed ID: 29959197
[TBL] [Abstract][Full Text] [Related]
12. The RHO Family GTPases: Mechanisms of Regulation and Signaling.
Mosaddeghzadeh N; Ahmadian MR
Cells; 2021 Jul; 10(7):. PubMed ID: 34359999
[TBL] [Abstract][Full Text] [Related]
13. Mutations in EMP2 cause childhood-onset nephrotic syndrome.
Gee HY; Ashraf S; Wan X; Vega-Warner V; Esteve-Rudd J; Lovric S; Fang H; Hurd TW; Sadowski CE; Allen SJ; Otto EA; Korkmaz E; Washburn J; Levy S; Williams DS; Bakkaloglu SA; Zolotnitskaya A; Ozaltin F; Zhou W; Hildebrandt F
Am J Hum Genet; 2014 Jun; 94(6):884-90. PubMed ID: 24814193
[TBL] [Abstract][Full Text] [Related]
14. DAAM2 Variants Cause Nephrotic Syndrome via Actin Dysregulation.
Schneider R; Deutsch K; Hoeprich GJ; Marquez J; Hermle T; Braun DA; Seltzsam S; Kitzler TM; Mao Y; Buerger F; Majmundar AJ; Onuchic-Whitford AC; Kolvenbach CM; Schierbaum L; Schneider S; Halawi AA; Nakayama M; Mann N; Connaughton DM; Klämbt V; Wagner M; Riedhammer KM; Renders L; Katsura Y; Thumkeo D; Soliman NA; Mane S; Lifton RP; Shril S; Khokha MK; Hoefele J; Goode BL; Hildebrandt F
Am J Hum Genet; 2020 Dec; 107(6):1113-1128. PubMed ID: 33232676
[TBL] [Abstract][Full Text] [Related]
15. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
Debidda M; Wang L; Zang H; Poli V; Zheng Y
J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
[TBL] [Abstract][Full Text] [Related]
16. Activation of type I phosphatidylinositol 4-phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42.
Weernink PA; Meletiadis K; Hommeltenberg S; Hinz M; Ishihara H; Schmidt M; Jakobs KH
J Biol Chem; 2004 Feb; 279(9):7840-9. PubMed ID: 14681219
[TBL] [Abstract][Full Text] [Related]
17. Defects of CRB2 cause steroid-resistant nephrotic syndrome.
Ebarasi L; Ashraf S; Bierzynska A; Gee HY; McCarthy HJ; Lovric S; Sadowski CE; Pabst W; Vega-Warner V; Fang H; Koziell A; Simpson MA; Dursun I; Serdaroglu E; Levy S; Saleem MA; Hildebrandt F; Majumdar A
Am J Hum Genet; 2015 Jan; 96(1):153-61. PubMed ID: 25557779
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin-mediated RhoGDI phosphorylation via PKCα promotes both RhoA and Rac1 signaling.
Sabbatini ME; Williams JA
PLoS One; 2013; 8(6):e66029. PubMed ID: 23776598
[TBL] [Abstract][Full Text] [Related]
19. TBC1D8B Loss-of-Function Mutations Lead to X-Linked Nephrotic Syndrome via Defective Trafficking Pathways.
Dorval G; Kuzmuk V; Gribouval O; Welsh GI; Bierzynska A; Schmitt A; Miserey-Lenkei S; Koziell A; Haq S; Benmerah A; Mollet G; Boyer O; Saleem MA; Antignac C
Am J Hum Genet; 2019 Feb; 104(2):348-355. PubMed ID: 30661770
[TBL] [Abstract][Full Text] [Related]
20. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
